Responses of somatostatin, beta-endorphin and dynorphin A to a glucose load in two groups of women with polycystic ovarian syndrome

Hormone Research in Paediatrics

Volumn 46, Issue 2, 1996, Pages 59-63

  Wu, Xiao Ke ^a   Wang, Chen Hai ^b   Su, Yan Hua ^a  

^a JINLING HOSPITAL   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Dynorphin A; Polycystic ovarian syndrome; Somatostatin; Endorphin

Indexed keywords

BETA ENDORPHIN; DYNORPHIN A; FOLLITROPIN; INSULIN; LUTEINIZING HORMONE; NEUROPEPTIDE; SOMATOSTATIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HORMONE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SOMATOSTATIN BLOOD LEVEL;

EID: 0029757369     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000184997     Document Type: Article

References (19)

1. Wu XK, Su YH: Types of hyperinsulinemia in polycystic ovarian syndrome, J Reprod Med 1994;3:80.
2. Chioderà P, Volpi R, Amato L, et al: Inhibition by somatostatin in I.H-RH induced LH release in normal menstruating women, Gynecol Ob-stct Invest 1986;22:17.
3. Ensinck JW, Laschansky EC, Vogel RE, et al: Effect of somatostatin on dynamics of insulin secretion in perfused rat pancreas, Diabetes 1991:40:1163.
4. Green IC, Perrin D, Penman E, et al: Effect of dynorphin on insulin and somatostatin secretion, calcium uptake, and cAMP levels in isolated rat islet of Langerhans, Diabetes 1983:32: 685.
5. Dale PO, Tanbo T, Vaaler S, et al: Body weight, hyperinsulinemia, and gonadotropin levels in the polycystic ovarian syndrome: Evidence of two distinct populations, Fertil Steril 1992:58: 487.
6. Prclevic GM, Warzburger MI, Nesic JS, et al: Effects of the somatostatin analogue, octreotide, in polycystic ovarian syndrome, Metabolism 1992;41 (9, suppl 2):76.
7. Nappi C, Petraglia F, Di-Carlo C, et al: Impairment of dopaminergic and opioidergic activity in patients with polycystic ovarian disease is restored by treatment for the induction of ovulation, Gynecol Obstct Invest 1989:27:38.
8. Desjardins GL, Beaudet A, Brawcr JR, et al: Alterations in opiod parameters in the hypothalamus of rats with estradiol-induced polycystic ovarian disease, Endocrinology 1990: 127:296.
9. Larmina E, Ditkolt EC, Malizia G, et al: Increased circulating levels of immunorcactive S-endorphin in polycystic ovary syndrome is not caused by increased pituitary secretion, Am J Obstet Gynecol 1992:167:181.
10. Aleem FA, Eltabbakh GH, Omar RA, et al: Ovarian follicular fluid beta-endorphin levels in normal and polycystic ovaries, Am J Obstet Gynecol 1987:156:1197.
11. Dahlgrcn E, Jogansson S, Lindstcdt G, et al: Women with polycystic ovarian syndrome wedge resected in 1956-1965: A long-term follow-up focusing on natural history and circulating hormones, Fertil Steril 1992:57:505.
12. Loiro V, Volpi R, Capretti L, et al: Luteinizing hormone response to gonadotropin-releasing hormone and naloxone in menstruating women with type 1 diabetes of different duration, Fertil Steril 1991:55:712.
13. Sahu A, Crowley WR, Kalca SP, et al: An opioid-neuropeptide Y transmission line to lu-teinizing-hormonc (LIl)-rclcasing hormone neurons: A role in the induction of LH surge, Endocrinology 1990:126:876.
14. Sahu A, Sninsky CA, Kalra PS, et al: Neuropeptide Y concentration in microdissccted hypothalamic regions and in vitro release from the medial basal hypothalamus-prcoptic area of strcptozotocin-diabetic rats with and without insulin substitution therapy, Endocrinology 1990:126:192.
15. Naim D, Vomen B, Burhol PG, et al: The interaction between cAMP-dependcnt and c.AMP-independent mechanisms in mediating the somatostatin inhibition of insulin secretion in isolated rat parcreatic islets, Acta Physiol Scand 1991:143:305.
16. Green IC, Tadayyon M: Opiate-prostaglandin interaction in the regulation of insulin secretion from rat islets of Langcrhans in vitro, Life Sci 1988:42:2123.
17. Lurry DL, Bennett LL, Li CH: Stimulation of insulin secretion by beta-endorphin, Life Sci 1987:40:2053.
18. Given JR, Kurtz BR, Kitabchi AE, et al: Reduction of hypcrinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans, J Clin Endocrinol Mctab 1987:64:377.
19. Guzick DS, Berga SL, Wing R, et al: Endocrine consequences of weight loss in obese, hyperandrogénie, anovulatory women, Fertil Steril 1994:61:58.